PBMCs were isolated from the heparinized blood samples of the three cattle with HISTOPAQUE 1.083 (Sigma-Aldrich, USA) according to the manufacturer's instructions, and then used in the identification of FMDV-specific plasmablasts. Highly purified FMDV O/Mya/98 (FMDV) inactivated 146S antigen was biotinylated with EZ-Link TM NHS-LC-Biotin reagent (Thermo Fisher Scientific, USA) according to the manufacturer's instructions, and the resulting biotin-FMDV 146S in combination with anti-biotin APC were used for the staining of FMDV-specific plasmablasts (34). For staining, freshly isolated PBMCs were first stained with biotin-FMDV 146S, anti-bovine CD21-PE (Bio-Rad, USA) and anti-bovine IgM-FITC (Bio-Rad, USA, labeled with FITC in-house) for 30 min at 4 • C in PBS buffer containing 2 mM EDTA and 0.5% BSA. Then, a second step antibody, mouse anti-biotin APC (Miltenyi Biotec, Germany), was added and incubated for 20 min at 4 • C. The parallel staining of PBMCs that lacked biotin-FMDV 146S was used as fluorescence minus one (FMO) control. These stained samples were immediately analyzed by flow cytometry and one million PBMCs were acquired for counting the proportion of FMDV-specific plasmablasts."The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
The inactivated vaccines of Foot-and-mouth disease virus (FMDV) have been used widely in the world to control Foot-and-mouth disease (FMD). But the virions (146S) of this virus are easily dissociated into pentamer subunits (12S), thus limits the immune protective efficacy of the inactivated vaccines when the temperature is higher than 30°C. The cold-chain system can maintain the quality of the vaccines, but that is usually not reliable in limited resource settings. Thus, it is imperative to improve the thermostability of vaccine strains to guarantee the vaccines’ quality. In this study, 4 recombinant FMDV strains containing single or multiple amino acids substitutions in the structural proteins (SP) were rescued by using a pre-constructed FMDV type O full-length infectious clone (pO/DY-VP1). The assays used here indicated that the single or multiple amino acids substitutions in SP may affect the viral replications to different degrees. Furthermore, the heat and acid stabilities of the recombinant viruses were significantly improved comparing with the parental virus. Three well thermally stable strains of recombinant viruses (rHN/DY-VP1Y2098F, rHN/DY-VP1V2090A-S2093H and rHN/DY-VP1V2090A-S2093H-Y2098F) were selected for inactivated vaccine to immunize pigs. Blood samples were collected every week to prepare sera. Meanwhile the effects of mutations in SP amino acids on the antigenicity were analyzed by viral neutralization test, which showed that the substitutions of S2093H, Y2098F and S2093H-Y2098F did not affect the immunogenicity. In addition, comparing to the parental virus, Y2098F mutation could increase the thermostability significantly (p<0.05). In conclusion, the rHN/DY-VP1Y2098F mutant is considered as a potential vaccine strain in the future.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.